Stay updated on ED-SCLC Immuno-Therapy Clinical Trial
Sign up to get notified when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.

Latest updates to the ED-SCLC Immuno-Therapy Clinical Trial page
- Check2 days agoChange DetectedLung cancer was added as a related topic and a MedlinePlus Genetics link was added; the page revision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check9 days agoChange DetectedThe page no longer displays the primary condition label 'Lung cancer' and the related topics/MedlinePlus Genetics sections, reducing contextual metadata and discoverability of the study's focus.SummaryDifference0.1%

- Check16 days agoChange DetectedAdded related topics 'Lung cancer' and 'MedlinePlus Genetics' to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check23 days agoChange DetectedExpanded the Locations section to include numerous new sites across US, Canada, Europe, Asia, and other regions, broadening geographic coverage for enrollment.SummaryDifference3%

- Check30 days agoChange DetectedLung cancer and related topics: MedlinePlus Genetics were removed from the page’s related topics/MeSH section. This affects indexing and discoverability but not the trial’s core details or participation information; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedEditorial updates clarify PubMed auto-fill and update the revision tag to v3.3.2 (from v3.2.0); these are minor wording changes that do not affect trial content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to ED-SCLC Immuno-Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.